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Abstract
Background: Online social networking and personally controlled health management systems (PCHMS) offer a
new opportunity for developing innovative interventions to prevent diseases of public health concern (e.g.,
influenza) but there are few comparative studies about patterns of use and impact of these systems.
Methods/Design: A 2010 CONSORT-compliant randomised controlled trial with a two-group parallel design will
assess the efficacy of a web-based PCHMS called Healthy.me in facilitating the uptake of influenza vaccine amongst
university students and staff. Eligible participants are randomised either to obtain access to Healthy.me or a 6-
month waitlist. Participants complete pre-study, post-study and monthly surveys about their health and utilisation
of health services. A post-study clinical audit will be conducted to validate self-reports about influenza vaccination
and visits to the university health service due to influenza-like illness (ILI) amongst a subset of participants. 600
participants older than 18 years with monthly access to the Internet and email will be recruited. Participants who
(i) discontinue the online registration process; (ii) report obtaining an influenza vaccination in 2010 before the
commencement of the study; or (iii) report being influenced by other participants to undertake influenza
vaccination will be excluded from analysis. The primary outcome measure is the number of participants obtaining
influenza vaccination during the study. Secondary outcome measures include: number of participants (i)
experiencing ILI symptoms, (ii) absent from or experiencing impairment in work or study due to ILI symptoms, (iii)
using health services or medications due to ILI symptoms; (iv) expressing positive or negative attitudes or
experiences towards influenza vaccination, via their reasons of receiving (or not receiving) influenza vaccine; and (v)
their patterns of usage of Healthy.me (e.g., frequency and timing of hits, duration of access, uptake of specific
functions).
Discussion: This study will provide new insights about the utility of online social networking and PCHMS for
public health and health promotion. It will help to assess whether a web-based PCHMS, with connectivity to a
health service provider, containing information and self-management tools, can improve the uptake of preventive
health services amongst university students and staff.
Trial registration: ACTRN12610000386033 (Australian New Zealand Clinical Trials Registry)
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Influenza is an important contributor to population
morbidity and mortality. Despite the unpredictable nat-
ure of influenza severity and spread on a population
scale, understanding the behaviour of individual patients
during seasons of respiratory disease has become essen-
tial for the planning and execution of successful public
health interventions. However, current knowledge is
based largely on observational studies, and randomised
controlled experiments that test different public health
interventions are urgently needed [1].
T h ep a n d e m i co fI n f l u e n z aAH 1 N 1( S w i n eF l u )i n
2009 and 2010 provided a major challenge to health ser-
vices around the world. Similar to previous pandemics,
it has led to significant aberrations in consumer beha-
viour, such as the stockpiling of goods, the victimisation
of specific population groups, the cancellation of travel
and the boycotting of particular foods (e.g., pork).
Furthermore, large regional differences in risk estima-
tion and risk perception have potentially affected the
uptake of vaccination and other public health measures
[2]. The pandemic prompted search for novel and inno-
vative containment interventions as many traditional
public health measures failed to control the spread of
influenza infection. In particular, increasing the uptake
of vaccination and ensuring compliance with contain-
ment policies have become a major challenge for public
health and health authorities. The clinical picture in
severe cases of pandemic (H1N1) 2009 influenza was
also markedly different from the disease pattern seen
during epidemics of seasonal influenza, in that many of
those affected were previously healthy young adults with
complex social interaction patterns. This group repre-
sents users of healthcare services who are most likely to
be receptive to personal health records (PHRs), offering
an opportunity to study and potentially modify health-
care information seeking and service utilization beha-
viour in young adults.
Online social networking and personally controlled
health management systems (PCHMS) offer a new
opportunity for developing innovative interventions to
prevent diseases of public health concern [3]. Health
promotion programs based on PCHMS can be used in a
variety of settings targeting a large range of health
issues, including the prevention of influenza [1]. Consu-
mers are increasingly using such online systems to
inform health decisions and manage their health. The
uptake of PCHMS is likely to vary in different social
groups under different conditions and within different
contexts [4], but few comparative studies are available
about patterns of use and impact of these systems.
It is thus important to ensure that design of studies to
test the impact of online PCHMS adequately reflects the
increased complexity of such interventions. This rando-
mised controlled trial (RCT) will make a specific and
significant contribution to our understanding on the
efficacy of using a web-based PCHMS called Healthy.
me, developed at the University of New South Wales, in
improving the uptake of influenza vaccination in a uni-
versity setting.
Study aims and hypotheses
Specific hypotheses to be tested in this study are that:
1. Consumers using a PCHMS are more likely to com-
ply with public health recommendations, as measured
by their rates of seeking and obtaining influenza
vaccination;
2. PCHMS that provides online facilities to schedule
encounters with a health service provider will increase
the utilisation rate of those services.
Methods/Design
Study design
A randomised controlled trial with a two-group parallel
design (with intervention allocation ratio 1:1) is used to
evaluate the efficacy of Healthy.me, reported in accor-
dance to the 2010 CONSORT statements (Figure 1) [5]:
￿ Participants randomised to the intervention group
will have immediate access to Healthy.me from the date
they are recruited in addition to health care of usual
standard.
￿ Participants randomised to the control group will
receive usual care. They will be allocated to a waiting
list and delayed to use Healthy.me by approximately six
months.
Participants and setting
Table 1 outlines participant inclusion and exclusion cri-
teria. The study will recruit students and staff members
at UNSW who are fluent in English. Written material
advertising the study outlines participant inclusion cri-
teria, which are self-explanatory (i.e. age ≥ 18 and
monthly access to Internet and email). Exclusion criteria
are applied post-study. Hence, participants who self-
identify as meeting inclusion criteria proceed to first
providing informed consent before commencing the
pre-study survey.
Participants engage in this trial online in their own
space at their own time. All participants are required to
complete online (i) a 5-10 minute pre-study survey; (ii)
a monthly one-minute survey to collect their health
symptoms and health service use; and (iii) a 5-10 minute
post-study survey. Participants allocated to the Healthy.
me group are also required to complete a five-minute
mandatory online tutorial about system before commen-
cing the study. Those who complete all study surveys
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completion.
Recruitment strategy
Five methods will be used to invite students and staff at
UNSW to participate in the study (to avoid influencing
consumer behaviour, it is not explicit to infer from
advertising material that the study is about influenza or
influenza vaccination):
1. Weekly and monthly advertisements circulated in
online and print newsletters and magazines to staff and
students.
2. Online announcements circulated for students and
staff on UNSW home page, myUNSW home page,
UNSW elearning portals and UNSW career websites.
3. Online annoucements circulated on Walls and dis-
cussion forums of Facebook accounts associated with
UNSW student clubs and societies on campus.
4. Email invitations sent to Heads of Schools, Heads of
UNSW departments, Heads of residential colleges, and
delegates of UNSW student clubs and societies for dis-
semination to staff and student mailing lists.
Figure 1 Overview of RCT process.
Table 1 Eligibility criteria for participants
Inclusion criteria Exclusion criteria
1. Aged 18 or above. 1. Participants who did not complete registration process [excluded before randomization].
1. Access to the Internet, and email at least
on a monthly basis.
2. Participants who self-reported having obtained an influenza vaccination in 2010 prior to enrolment
in the study [excluded from analysis].
3. Participants who self-reported to be influenced by other participants during the study to obtain (or
not obtain) influenza vaccination [excluded from analysis].
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across the university campus.
Ethical concerns and consent
Ethics approval for this study was obtained from the
UNSW Human Research Ethics Committee. Participants
provide written consent online; the revocation of con-
sent form is also available online.
Intervention and control
Volunteers responding to the invitation are required to
register online by providing consent, and completing the
pre-study survey and the tutorial about Healthy.me.
The control and intervention arms of the trial run
concurrently, meaning that the randomly allocated parti-
cipants of the trial are exposed to the same influenza
season and the same background of public health mes-
saging. The only difference between the 2 arms is expo-
sure to the intervention. Whilst there are clear annual
differences in flu and vaccination rates, our study should
detect if in a given year we are able to change consumer
behaviour. It is likely that in different years the degree
of effect will differ, and only long term and longitudinal
studies would help us understand the underlying trend.
Such studies would be contemplated after strong evi-
dence from this study that the intervention in principle
is capable of impacting behaviour in a single season.
Description of intervention
The intervention in this trial is a web-based PCHMS
called Healthy.me, which consists of the following fea-
tures (Figure 2):
1. Personal Record: Allows for self-recording of medi-
cal test results and health measurements (not available
to participants in this study).
2. Pillbox: Allows for self-recording of current medica-
tions and medication adherence.
3. Schedule, to-do list and reminders: An online sche-
dule to self-record and keep track of health-related
appointments, to-do items, which sends email
reminders.
4. Team: A feature that allows the self-recording of
clinical and non-clinical personnel looking after one’s
health.
5. Journeys: Consumer-specific care pathways that
provide knowledge in an actionable way. A feature that
describes the different stages in the management of
health conditions that can be used to personalise other
PHR sections in the system, and provides advice on
what to expect and how to prepare for each stage. (Par-
ticipants in this study had access to an influenza vaccine
journey).
6. Social features for this study included: (i) a profile
for each member to store and customise their personal
information, (ii) the ability to send and receive messages
with other members on Healthy.me.
Studies suggest that by addressing both knowledge-
based (e.g. lack of awareness) and system-based (e.g.
inconvenience) barriers in accessing health services,
patients and consumers are more likely to uptake pre-
ventative health measures, such as influenza vaccination
[6]. Our PCHMS is designed to address both knowl-
edge-based and system-based barriers faced by consu-
mers when accessing and utilising health services.
The PCHMS thus integrates a number of tools to
address knowledge and system barriers that influence
consumers’ engagement with health services. Our
PCHMS contains a PHR, as well as online social net-
working mechanisms that allow participants to interact
with healthcare professionals at the service provider and
other consumers, and additional tools to support consu-
mer decision making and subsequent task management.
In addition, it is integrated with consumer-specific care
pathways (called “journeys”)t h a tp r o v i d ek n o w l e d g ei n
an actionable way. For example, at the point that a con-
sumer encounters advice to seek influenza vaccination,
they are immediately able to book an appointment with
a medical practitioner, or set themselves a reminder.
T h eP C H M Sw a sp r e v i o u s l yt e s t e di nas m a l lt r i a l
with women undergoing in-vitro fertilisation (IVF), to
demonstrate system usability and acceptance. Interview
data from this trial provided evidence that the system
positively impacted consumer advice-seeking behaviours
[7].
The influenza vaccine journey in Healthy.me was
iteratively developed and validated in consultation with
the University Health Service (i.e. university’s general
practice) (Figure 3). It utilises government-endorsed evi-
dence-based consumer education material that had been
Figure 2 Features of Healthy.me (
© University of New South
Wales, 2009-2012).
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munity about seasonal influenza and pandemic H1N1
influenza [8-11].
Intervention group and exposure
The period of access to Healthy.me will vary depending
on the date of participant registration. During the study
Healthy.me will provide participants in the intervention
group with information and forward email reminders
about influenza, indications for vaccination, as well as
an email link to the University Health Service for parti-
cipants to book an appointment for influenza vaccina-
tion or other medical concerns, should they wish to use
that service (Figure 4).
The intervention will not modify in any way the stan-
dard procedures of healthcare provision by the Univer-
sity Health Service. Only administrative staff at the
practice would receive requests for appointments facili-
tated by Healthy.me; no clinical staff assessing patient
outcomes and/or administrating influenza vaccination
would receive these appointment requests.
A pilot was conducted in a controlled university set-
ting with three men and three women of different ethnic
and cultural backgrounds and age groups, representative
of the university student and staff population. Substan-
tive issues on system usability, journey content, surveys,
study protocol and advertisement material were resolved
before recruiting UNSW students and staff to participate
in their normal setting.
Control
Participants in the control group will receive delayed
access to Healthy.me by approximately 6 months.
Sample size considerations
The sampling unit is the participant and the unit of ana-
lysis is also the participant. A conservative estimate of
600 participants with 300 in each group is needed to
detect a 10% difference in influenza vaccination rate
between the control group (15%) and the intervention
group (25%). This estimate is calculated at 5% level of
significance, 80% power (two-sided test), with an antici-
pated participant dropout rate around 10% [12].
The effect size estimate is based on a review assessing
the effectiveness of patient reminder systems in improving
immunization rates, which can range from 5 to 20% [13].
The baseline rate estimate of influenza vaccination was
informed by our audit conducted at the University Health
Service, showing 16% of patients at the practice received
FluVax or PanVax between 5/3/2009 to 5/11/2009. This
estimate is also supported by literature reporting 18 to
30% of university students and healthy adults (18 to 49
years old) obtaining influenza vaccination in a year [14,15].
Outcome measures
Table 2 outlines the primary and secondary outcome
measures in this study. Participants in control and inter-
vention groups who are analysed for primary outcome
will have completed the post-study survey and/or pro-
vided influenza vaccination status by de-identified clini-
cal audit. Participants in intervention group who had
the opportunity to use Healthy.me but did not do so
will be included in the primary analysis. Participants
who met the exclusion criteria or whose influenza vacci-
nation status was unavailable at study completion will
be excluded.
Influenza like-illness (ILI) case definition
ILI symptoms are based upon case definitions of influ-
enza issued by NSW Health and Centers for Disease
Control and Prevention (CDC) as of 26 March 2010
[16,17]. Febrile upper respiratory tract illnesses occur-
ring during the peak influenza period was identified as
the most specific clinical case definition expected to
have the highest positive predictive value for true influ-
enza [18].
Data collection
Four methods will be used to collect data about partici-
pants during the study:
Figure 3 Top page of Healthy.me influenza vaccine journey (
©
University of New South Wales, 2009-2012).
Figure 4 Booking appointment with University Health Service
on Healthy.me (
© University of New South Wales, 2009-2012).
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ILI symptoms in the Australian community [19,20], and
studies investigating influenza experiences and attitudes
amongst university students and healthy working adults
[14,21-26]. The following surveys will be conducted:
￿ Pre-study survey to obtain participant demographics
and health status at study registration.
￿ Monthly one-minute follow-up surveys to obtain
participant self-reported symptoms of ILI, use of health
services, and impact on work and study due to ILI
symptoms throughout the study.
￿ Post-study survey to obtain participant influenza
vaccination status. For those who receive Healthy.me
intervention, they will be asked in addition for their per-
ceived usefulness of Healthy.me.
System logs: During the study, participant actions on
Healthy.me will be unobtrusively logged.
Personal health data: Data entered by participants into
Healthy.me about their health (e.g., medications used,
scheduled tasks and appointments, members in health-
care team).
Clinical audit: This will be conducted post-study for
patients at the University Health Service (UHS), to vali-
date self-reports of vaccination and visits to a healthcare
professional related to ILI symptoms for a subset of par-
ticipants before and during the study. Clinical audits
will be conducted on site at the UHS, linking UHS
patient records with our survey data using exact
matches on participants’ surname, date of birth, and an
approximate match on first-name. Extracted records will
be replaced with a de-identified ID, and all names will
be removed prior to analysis.
Analysis plan
Statistical significance is defined a priori as a P value of
less than 0.05 (determined using a two-tailed test). Data
will be collected by online survey software KeySurvey
[27] and analysed using PASW Statistics 18 [28].
Baseline comparisons
Comparisons of baseline variables between PCHMS and
waitlist groups will be conducted using Student’st - t e s t s
for continuous variables and c
2 tests for categorical vari-
ables, to assess whether randomisation was performed
properly. Adjustment for baseline characteristics is
planned to correct for possible imbalance between the
randomised groups and to provide a stratified estimate
of the effect of intervention if applied [29,30].
Primary analysis
Differences in proportions of participants obtaining
influenza vaccination during the study will be compared
between waitlist and PCHMS groups. All intervention
recipients who had the opportunity to use the PCHMS
but did not do so will be included in the primary analy-
sis. Differences in participant proportions between wait-
list and PCHMS groups will be analysed using c
2 test.
Proportions will be reported with 95% confidence
intervals.
Adjustments for baseline characteristics and potential
confounders will be made through the use of sequential
logistic regression [31]. Baseline characteristics (Table
Table 2 Primary and secondary outcome measures collected at different time points
Outcome measure Measurement timepoints & methods
Primary outcome
Proportion of participants obtaining influenza vaccination during the
study
￿ Study completion
1 (via self-reports and clinical audit)
Secondary outcome
Proportion of participants visiting the University Health Service during
the study
￿ Study completion
1 (via self-reports and clinical audit)
Ancillary outcomes
Proportion of participants experiencing symptoms of influenza-like
illness
2 (ILI) during the study
￿ Monthly from study commencement in May to October 2010 (via self-
reports)
Proportion of participants using medications or remedy due to ILI
symptoms
2
￿ Monthly from study commencement in May to October 2010 (via self-
reports)
Proportion of participants visiting a healthcare professional due to ILI
symptoms
2
￿ Monthly from study commencement in May to October 2010 (via self-
reports)
Proportion of participants experiencing impairment in work or study
due to ILI symptoms
2
￿ Monthly from study commencement in May to October 2010 (via self-
reports)
Number of days absent from work or study due to ILI symptoms (per
participant)
￿ Monthly from study commencement in May to October 2010 (via self-
reports)
Reasons for receiving (or not receiving) influenza vaccine ￿ Study completion
1 (via self-reports)
Patterns of usage and feedback of PCHMS ￿ Study completion
1 (via automatic system logs, data entered by participants
into PCHMS, and self-reports)
1Estimated end of average respiratory disease and influenza season in Southern Hemisphere (i.e. October 2010, six months from study commencement)
2Defined by case definitions of influenza (fever with cough or a sore throat) issued by NSW Health and Centers for Disease Control and Prevention (CDC) aso f2 6
March 2010
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lected at post study (i.e. contact with children during
study, past history of influenza vaccine) will be entered
at Step 1 of the regression; and group allocation
(PCHMS vs. waitlist) will be entered at Step 2.
Secondary and ancillary analyses
Differences in proportions of participants between dif-
ferent groups (e.g. waiting list vs. PCHMS; used
PCHMS once vs. used PCHMS more than once) will be
examined using c
2 test for each of the following activ-
ities experienced at least once during the study: i) visited
the University Health Service (or a healthcare profes-
sional); ii) used medications or remedy; and iii) experi-
enced performance impairment. Differences in average
number of days of absence per participant will be com-
pared between waitlist and PCHMS groups using Stu-
dent’s t-test. Reasons for receiving (or not receiving)
influenza vaccine and impact of ILI symptoms will be
reported using descriptive statistics.
Study procedure
Table 3 summarizes participant procedures in the study.
The duration of the study is expected to be six months
from May 2010 to October 2010.
Email will be the primary channel to communicate
with participants for study information and reminders
about survey completion. From the time participants are
recruited until study completion, all participants (control
& intervention) will receive an email in the first week of
each month to complete a one-minute survey about
their health in the past month. At study completion, all
participants will receive an email asking them to com-
plete a post-study survey. Two follow-up emails five
days apart from each other will be sent to remind those
who have not completed each survey to ensure the com-
pleteness of data collection.
Randomisation and allocation concealment
After consent each participant is randomly allocated to
the intervention or control group, facilitated by a com-
puterised centralised allocation process which forms
part of the online registration procedure. Eligible health-
care consumers are randomly assigned to the interven-
tion or control group using a computer generated
random number sequence in randomly assigned blocks
(block sizes 2, 4 and 8) with intervention allocation ratio
of 1:1 [32].
The randomisation sequence generation, participant
registration, and group allocation processes are compu-
terised online and do not involve human interventions
from the investigators. The block randomisation
sequence is pre-generated by a member external to the
research team using a computerised random-number
generator before commencing participant recruitment.
As each participant completes the online registration
procedure, he/she receives the next consecutive alloca-
tion in the sequence, which automatically assigns the
consumer to the intervention or control group.
Blinding and assessment
Since Healthy.me is a behavioural intervention it is not
possible to completely blind participants to the interven-
tion. The group allocation is revealed to participants
only after obtaining their consent to participate in the
study and completion of the pre-study survey. However,
investigators and clinicians involved in the study are
blinded to group allocation. To minimise contamination
of control participants who might interact with partici-
pants who are part of the intervention group, partici-
pants in the intervention gro u pa r ea s k e dn o tt os h a r e
their Healthy.me access details with other people.
Further, participants who self-reported to have been
influenced by others participating in the study to obtain
(or not obtain) influenza vaccination will be excluded
from analysis. To assess the success of blinding, admin-
istrative staff at the University Health Service will be
consulted at study completion to confirm whether clini-
cians involved in assessing patient outcomes and/or
administrating influenza vaccination are able to distin-
guish patients who booked an appointment using
Healthy.me.
Discussion
Health promotion and surveillance have received unpre-
cedented recognition because of newly emerging and re-
emerging infectious diseases with epidemic potential,
new cycles of pandemics, and the threats of bioterror-
ism. Influenza and influenza-like illness (ILI) are
Table 3 Stages of study procedure
Stage of study Procedure
Online registration - Participant registration, study consent and Healthy.me tutorial (self-completed online)
Baseline - Pre-study survey (self-completed online)
- Data from de-identified clinical audit from previous 12 months: electronic extraction (collected post-study)
Follow-up procedures - Monthly one-minute surveys (self-completed online)
- Post-study survey (self-completed online)
- Patterns of Healthy.me use (computer logs and data entered by participants)
- De-identified clinical audit at study completion: electronic extraction (collected post-study)
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morbidity and mortality. The recent influenza pandemic
with novel H1N1 has highlighted the need for a better
understanding of patients’ healthcare seeking behaviour
and perceptions and attitudes towards vaccination. Find-
ings of our study will help to facilitate health promotion
and surveillance in technology savvy populations as well
as to enhance healthcare professionals’ and govern-
ments’ capacity to predict and prepare for the subse-
quent epidemics and pandemics.
The study will further explore the role of clinical ill-
ness case definitions for influenza as methods used to
define influenza seasons have varied substantially. These
differences often result in differing levels of sensitivity,
specificity and positive predictive value for the case defi-
nitions used. Furthermore, these differences affect the
estimation of influenza vaccine effectiveness, safety and
cost benefit analyses in healthy working adults [24,33].
Limitations
There are several potential limitations in this study:
￿ Number of eligible participants: Recruitment may be
affected by an overlap between the start of respiratory
season in Australia and the student examination period,
potentially affecting student and staff availability and
interest to participate in research studies. The number
of participants meeting exclusion criteria at study com-
pletion might be significant because staff members are
eligible for free influenza vaccination offered by UNSW
one week prior to study commencement. As free vacci-
nation would be a confounder if included in this trial,
we explicitly ran our campaign independently of the
university program.
￿ Self-reports of influenza vaccination and health ser-
vice utilisation: Since clinical audits will only be con-
ducted at the University Health Service, and not other
GP practices, the study is dependent on participants’
self-reporting of their influenza vaccination and health
service utilisation. Self report has shown to be accepta-
bly accurate in numerous studies examining days of
absence [34], influenza symptoms, and vaccination sta-
tus for diverse patient cohorts [20,33,35-38]. We will
minimise the risk of recall bias by conducting short
one-minute monthly follow-up surveys on the first week
of each month.
￿ Representative of general healthcare consumers:T h e
study may be more appealing to consumers who are
interested or literate in computers, the Internet, or
health-related topics. These participants may be more
enthusiastic about health and the Internet than the gen-
eral health consumer population. In addition, partici-
pants from a university setting are more likely to be
open and positive to new research ideas and willing to
participate in research studies. Further, generalisability
of findings could be limited by recruiting participants
from one university.
￿ Social influence and access to Healthy.me: The social
networks of individual participants may span the inter-
vention and control arms of this study, and see inter-
vention subjects un-blind control subjects with
information obtained from the intervention. As this is a
pragmatic trial in the real world, such effects cannot be
controlled for. Indeed participants’ social networks are
likely to influence access to Healthy.me if the interven-
tion was in routine use. We will attempt to measure this
effect by asking participants in the control arm if they
have been in contact with intervention arm subjects. If a
significant group is identified, we will conduct separate
analyses to estimate the impact of any such effect on
overall trial results.
￿ Baseline comparisons:A st h i si sap r a g m a t i ct r i a lo f
a multifaceted intervention in a complex environment, it
is possible that baseline variables associated with sub-
jects might also influence the outcome. For example,
having a prior history of obtaining influenza vaccination
may predict future vaccination rates, independently of
any additional intervention. We will identify potential
baseline variables that might influence outcome, includ-
ing gender, and test for unequal distribution of these
variables in the intervention and control populations.
Should there be a significant difference in their distribu-
tion due to chance bias, these will be fitted in an analy-
sis of covariance to model their impact on any observed
differences between the two arms [39].
Concluding remarks
Our design of this randomised controlled trial (RCT)
focuses on the comparison of outcomes that unequivo-
cally reflect a change in consumer behaviour, and takes
into account the complexity of intervention. Results of
this study will offer new insights about the utility of
online social networking for public health and health
promotion. Our findings will provide specific answers to
whether using a web-based PHCMS, with connectivity
to a health service provider, containing information and
self-management tools that facilitate consumers to act
on a decision, will improve the uptake of preventive
health services amongst students and staff in a univer-
sity setting.
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